Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Cancer Cell
|
June 7, 2016
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
Rony Dahan, Bryan C Barnhart, Fubin Li, et al.
Journal of Autoimmunity
|
October 5, 2013
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope
Rony Dahan, John A Gebe, Anton Preisinger, et al.
Nature Cancer
|
February 22, 2022
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, et al.
Science Immunology
|
March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Nature Immunology
|
July 22, 2014
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic, Stylianos Bournazos, David J DiLillo, et al.
Nature Immunology
|
March 6, 2019
BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches
Adi Biram, Anneli Strömberg, Eitan Winter, et al.
Journal of Neuroscience Research
|
September 17, 2004
HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes
Thomas P Finn, Richard E Jones, Cathleen Rich, et al.
Immunity
|
April 25, 2026
Pharmacologic glycoengineering of Fcγ receptor IIIa enhances force-resistant IgG-FcγR interactions and anti-tumor antibody efficacy
Bowie Yik-Ling Cheng, Raquel M Centeio, David Kung-Chun Chiu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS
Sushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
European Journal of Immunology
|
April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes
Rony Dahan, Moran Tabul, Yuan K Chou, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Cancer Cell
|
June 7, 2016
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
Rony Dahan, Bryan C Barnhart, Fubin Li, et al.
Journal of Autoimmunity
|
October 5, 2013
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope
Rony Dahan, John A Gebe, Anton Preisinger, et al.
Nature Cancer
|
February 22, 2022
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, et al.
Science Immunology
|
March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Nature Immunology
|
July 22, 2014
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic, Stylianos Bournazos, David J DiLillo, et al.
Nature Immunology
|
March 6, 2019
BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches
Adi Biram, Anneli Strömberg, Eitan Winter, et al.
Journal of Neuroscience Research
|
September 17, 2004
HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes
Thomas P Finn, Richard E Jones, Cathleen Rich, et al.
Immunity
|
April 25, 2026
Pharmacologic glycoengineering of Fcγ receptor IIIa enhances force-resistant IgG-FcγR interactions and anti-tumor antibody efficacy
Bowie Yik-Ling Cheng, Raquel M Centeio, David Kung-Chun Chiu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS
Sushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
European Journal of Immunology
|
April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes
Rony Dahan, Moran Tabul, Yuan K Chou, et al.
Page
of 4